NEW YORK, April 4 (GenomeWeb News) - Ferrer International and Oryzon Genomics have formed a collaboration to develop new genomic- and proteomic-based products for the early diagnosis and prognosis of colorectal cancer, the firms said yesterday.
The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.
